Pancreas mass Cancer
Conditions
Interventions
EUS FNA
The randomization sequence of the needle size was created with a 1:1 allocation using blocks of four without stratification. The allocation was achieved in the operating room by physicians bli
Sponsors
Geneva University Hospital (Switzerland)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Only adults over 18 years were eligible for the study. They all presented to our service with a solid pancreatic mass identified by at least two dissimilar imaging modalities (ultrasound, CT scan, MRI).
Exclusion criteria
Exclusion criteria: 1. Sepsis 2. Acute pancreatitis defined as abdominal pain associated with increased serum lipase > 3 the normal value) 3. Anticoagulant therapy 4. Antiaggregant therapy other than aspirin 5. Previous history of modified anatomy interfering with endoscopic assessment 6. Incapacity to give informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tissue sample was examined under the microscope. All slides were evaluated for the amount of blood found on the smears, digestive contamination, pancreatic cellularity and final diagnosis. The final diagnosis was based on cytology report, surgical pathology if available, repeated radiological imaging and clinical follow-up. | — |
Secondary
| Measure | Time frame |
|---|---|
| FNA complications | — |
Countries
Switzerland
Outcome results
None listed